Evaluation of Prognosis With Integrated MRI/PET in Patients With Pancreatic Cancer

Evaluation of Prognosis With Integrated MRI/PET in Patients With Pancreatic Cancer

The aim of this study was to evaluate MR/PET with both functional and molecular imaging on the prediction of prognosis in patients with suspected pancreatic cancer.

The results of MR/PET will be compared prospectively to dedicated MDCT or MR imaging, pathologic results, and clinical outcomes to assess the value of MR/PET in pancreatic cancers.

Inclusion Criteria:

1. Diagnosed as pancreatic cancer
2. Between 20~90 years old
3. ECOG 0-2
4. Normal renal function
5. Measurable tumor size (>1cm)

Exclusion Criteria:

1. Contraindication for MRI exam
2. Claustrophobia
3. Renal insufficiency
4. Other malignancy
5. Pregnancy and lactating women